Auditor�a
de la seguridad y la eficacia de la ketamina para la sedaci�n de
procedimientos en el servicio de
urgencias
|
Audit
of the safety and effectiveness of ketamine for procedural sedation
in the emergency department
J M Vardy, N Dignon, N Mukherjee, D M Sami, G Balachandran, S
Taylor.
Emerg Med J 2008;25:579-582
doi:10.1136/emj.2007.056200
Abstract
Aim: To examine the effectiveness and safety of the sedative agents
used in the emergency department following the introduction of
ketamine as an agent for procedural sedation. Methods: A 2-year
prospective audit of sedation practice was undertaken. This
specifically examined the rationale behind a doctor's choice of
sedative agent, the depth of sedation achieved, adverse events and
the time taken to regain full orientation. Results: 210 patients
were included of whom 85 (40%) were given ketamine, 107 (51%)
midazolam and 18 (9%) propofol. The median time to full orientation
was 25 min for ketamine, 30 min for midazolam and 10 min for
propofol. Complications occurred in 15.9% of sedations overall
(14.6% of those given ketamine, 15.8% given midazolam and 22.2%
given propofol). Apnoea and hypoxia most often occurred with
midazolam and propofol, while hypertension and hypertonicity were
encountered more frequently with ketamine. In addition, 19.5% of
patients given ketamine suffered the re-emergence phenomenon. The
association between deep sedation with no response to pain and
adverse events encountered with midazolam does not occur with
ketamine. Conclusions: Ketamine is both safe and effective and
compares favourably with midazolam as an agent for procedural
sedation in the emergency department. Although the re-emergence
phenomenon occurred, no psychological sequelae were encountered
after return to full orientation. Ketamine may be particularly
useful in groups of patients at high risk of adverse effects with
midazolam
Art�culo en
PDF
|